Side-by-side comparison of AI visibility scores, market position, and capabilities
Industrial compressor and fluid management leader; $7.3B FY2024 revenue; ILC Dover acquisition 2024 adds defense/biopharma; competes with Atlas Copco; CHIPS Act semiconductor fab demand driver.
Ingersoll Rand is a global industrial manufacturer specializing in mission-critical compressed air systems, fluid management, and power tools, with origins dating to 1871 when Simon Ingersoll patented the first practical steam rock drill. The modern company was formed in 2020 when Gardner Denver—itself a compressed air and industrial technology company—acquired the Industrial segment of legacy Ingersoll-Rand and renamed itself Ingersoll Rand Inc., trading on NYSE (IR). Headquartered in Davidson, North Carolina, the company generated approximately $7.3 billion in revenues for FY2024 under CEO Vicente Reynal, who has emphasized a "Win Strategy" of consistent organic growth, margin expansion, and bolt-on M&A to build a premier industrial platform.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.